|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
US5457194A
(en)
|
1993-03-17 |
1995-10-10 |
Abbott Laboratories |
Substituted aliphatic amine-containing macrocyclic immunomodulators
|
|
US5798355A
(en)
|
1995-06-07 |
1998-08-25 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
US5696135A
(en)
|
1995-06-07 |
1997-12-09 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
|
|
US7056935B2
(en)
|
1995-06-07 |
2006-06-06 |
Gpi Nil Holdings, Inc. |
Rotamase enzyme activity inhibitors
|
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
|
EP1352910A1
(en)
|
2002-04-10 |
2003-10-15 |
Grünenthal GmbH |
New analogs of nitrobenzylthioinosine
|
|
WO2004093798A2
(en)
|
2003-04-18 |
2004-11-04 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
|
|
US20060003362A1
(en)
|
2004-06-04 |
2006-01-05 |
Xenoport, Inc. |
ENT1 transporters expressed in cancer cells
|
|
GB0417852D0
(en)
|
2004-08-11 |
2004-09-15 |
Biotica Tech Ltd |
Production of polyketides and other natural products
|
|
JP2009513135A
(ja)
|
2005-10-28 |
2009-04-02 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
エンコードされたライブラリーを用いて興味のある化合物を同定する方法
|
|
US20080306098A1
(en)
|
2006-11-06 |
2008-12-11 |
Mutz Mitchell W |
Pharmacokinetics of protease inhibitors and other drugs
|
|
EP3417859A1
(en)
|
2007-03-07 |
2018-12-26 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
JP2010527618A
(ja)
|
2007-05-24 |
2010-08-19 |
アメリカ合衆国 |
ヌクレオシドサルベージ経路を通しての核内タンパク質伝達
|
|
WO2010004304A1
(en)
|
2008-06-17 |
2010-01-14 |
Biotica Technology Limited |
Novel compounds and methods for their production
|
|
AU2011336727B2
(en)
*
|
2010-11-30 |
2016-11-03 |
The Johns Hopkins University |
Hybrid cyclic libraries and screens thereof
|
|
WO2012106702A2
(en)
|
2011-02-04 |
2012-08-09 |
The General Hospital Corporation |
Treatment of leukemia
|
|
EP2607352A1
(en)
|
2011-12-22 |
2013-06-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-diketoamides for treatment of psychiatric disorders
|
|
KR101733736B1
(ko)
|
2012-01-06 |
2017-05-10 |
삼성에스디아이 주식회사 |
리튬 이차 전지용 음극 활물질, 그 제조 방법 및 이를 포함하는 리튬 이차 전지
|
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
|
US10167259B2
(en)
|
2013-06-14 |
2019-01-01 |
The Board Of Regents Of The University Of Texas System |
Allosteric inhibitors of proteasome and methods of use thereof
|
|
WO2016112295A1
(en)
|
2015-01-09 |
2016-07-14 |
Warp Drive Bio, Inc. |
Compounds that participate in cooperative binding and uses thereof
|
|
CA3000822A1
(en)
|
2015-10-01 |
2017-04-06 |
Warp Drive Bio, Inc. |
Methods and reagents for analyzing protein-protein interfaces
|
|
CN108697729B
(zh)
|
2016-02-04 |
2023-05-09 |
约翰霍普金斯大学 |
新型GLUT抑制剂rapaglutin及其用途
|
|
WO2017136708A1
(en)
|
2016-02-04 |
2017-08-10 |
The Johns Hopkins University |
Synthesis and composition of rapafucin libraries
|
|
US11066416B2
(en)
|
2016-02-04 |
2021-07-20 |
The Johns Hopkins University |
Rapafucin derivative compounds and methods of use thereof
|
|
AU2017214557B2
(en)
*
|
2016-02-04 |
2022-05-19 |
The Johns Hopkins University |
Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
|
|
CR20180499A
(es)
|
2016-04-22 |
2019-01-25 |
Astrazeneca Ab |
Inhibidores de mcl1 macrocicliclos para tratar el cancer
|
|
US20190224274A1
(en)
|
2016-09-02 |
2019-07-25 |
The Johns Hopkins University |
Mif inhibitors and methods of use thereof
|
|
UY37900A
(es)
|
2017-09-26 |
2019-04-30 |
Novartis Ag |
Nuevos derivados de rapamicina
|